BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3483 related articles for article (PubMed ID: 22300766)

  • 1. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.
    Koboldt DC; Zhang Q; Larson DE; Shen D; McLellan MD; Lin L; Miller CA; Mardis ER; Ding L; Wilson RK
    Genome Res; 2012 Mar; 22(3):568-76. PubMed ID: 22300766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inferring copy number and genotype in tumour exome data.
    Amarasinghe KC; Li J; Hunter SM; Ryland GL; Cowin PA; Campbell IG; Halgamuge SK
    BMC Genomics; 2014 Aug; 15(1):732. PubMed ID: 25167919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
    PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.
    Franch-Expósito S; Bassaganyas L; Vila-Casadesús M; Hernández-Illán E; Esteban-Fabró R; Díaz-Gay M; Lozano JJ; Castells A; Llovet JM; Castellví-Bel S; Camps J
    Elife; 2020 Jan; 9():. PubMed ID: 31939734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data.
    Favero F; Joshi T; Marquard AM; Birkbak NJ; Krzystanek M; Li Q; Szallasi Z; Eklund AC
    Ann Oncol; 2015 Jan; 26(1):64-70. PubMed ID: 25319062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hierarchical discovery of large-scale and focal copy number alterations in low-coverage cancer genomes.
    Khalil AIS; Khyriem C; Chattopadhyay A; Sanyal A
    BMC Bioinformatics; 2020 Apr; 21(1):147. PubMed ID: 32299346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SynthEx: a synthetic-normal-based DNA sequencing tool for copy number alteration detection and tumor heterogeneity profiling.
    Silva GO; Siegel MB; Mose LE; Parker JS; Sun W; Perou CM; Chen M
    Genome Biol; 2017 Apr; 18(1):66. PubMed ID: 28390427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data.
    do Valle ÍF; Giampieri E; Simonetti G; Padella A; Manfrini M; Ferrari A; Papayannidis C; Zironi I; Garonzi M; Bernardi S; Delledonne M; Martinelli G; Remondini D; Castellani G
    BMC Bioinformatics; 2016 Nov; 17(Suppl 12):341. PubMed ID: 28185561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-exome sequencing reveals potential germline and somatic mutations in 60 malignant ovarian germ cell tumors†.
    Chen J; Li Y; Wu J; Liu Y; Kang S
    Biol Reprod; 2021 Jul; 105(1):164-178. PubMed ID: 33739378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CloneCNA: detecting subclonal somatic copy number alterations in heterogeneous tumor samples from whole-exome sequencing data.
    Yu Z; Li A; Wang M
    BMC Bioinformatics; 2016 Aug; 17():310. PubMed ID: 27538789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of methods for identifying somatic copy number alterations from deep sequencing data.
    Alkodsi A; Louhimo R; Hautaniemi S
    Brief Bioinform; 2015 Mar; 16(2):242-54. PubMed ID: 24599115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CONSERTING: integrating copy-number analysis with structural-variation detection.
    Chen X; Gupta P; Wang J; Nakitandwe J; Roberts K; Dalton JD; Parker M; Patel S; Holmfeldt L; Payne D; Easton J; Ma J; Rusch M; Wu G; Patel A; Baker SJ; Dyer MA; Shurtleff S; Espy S; Pounds S; Downing JR; Ellison DW; Mullighan CG; Zhang J
    Nat Methods; 2015 Jun; 12(6):527-30. PubMed ID: 25938371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation discovery in regions of segmental cancer genome amplifications with CoNAn-SNV: a mixture model for next generation sequencing of tumors.
    Crisan A; Goya R; Ha G; Ding J; Prentice LM; Oloumi A; Senz J; Zeng T; Tse K; Delaney A; Marra MA; Huntsman DG; Hirst M; Aparicio S; Shah S
    PLoS One; 2012; 7(8):e41551. PubMed ID: 22916110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BACOM: in silico detection of genomic deletion types and correction of normal cell contamination in copy number data.
    Yu G; Zhang B; Bova GS; Xu J; Shih IeM; Wang Y
    Bioinformatics; 2011 Jun; 27(11):1473-80. PubMed ID: 21498400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetic landscape of 87 ovarian germ cell tumors.
    Van Nieuwenhuysen E; Busschaert P; Neven P; Han SN; Moerman P; Liontos M; Papaspirou M; Kupryjanczyk J; Hogdall C; Hogdall E; Oaknin A; Garcia A; Mahner S; Trillsch F; Cibula D; Heitz F; Concin N; Speiser P; Salvesen H; Sehouli J; Lambrechts D; Vergote I
    Gynecol Oncol; 2018 Oct; 151(1):61-68. PubMed ID: 30170975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.
    Zhang J; Zhang S; Wang Y; Zhang XS
    BMC Syst Biol; 2013; 7 Suppl 2(Suppl 2):S4. PubMed ID: 24565034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-based comparative analysis of tools for estimating copy number alterations using whole-exome sequencing data.
    Kim HY; Choi JW; Lee JY; Kong G
    Oncotarget; 2017 Apr; 8(16):27277-27285. PubMed ID: 28460482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ExScalibur: A High-Performance Cloud-Enabled Suite for Whole Exome Germline and Somatic Mutation Identification.
    Bao R; Hernandez K; Huang L; Kang W; Bartom E; Onel K; Volchenboum S; Andrade J
    PLoS One; 2015; 10(8):e0135800. PubMed ID: 26271043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational analysis in cancer exome sequencing.
    Evans P; Kong Y; Krauthammer M
    Methods Mol Biol; 2014; 1176():219-27. PubMed ID: 25030931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.
    Buckley AR; Ideker T; Carter H; Harismendy O; Schork NJ
    Genome Med; 2018 Sep; 10(1):69. PubMed ID: 30217226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 175.